Technological advancement holds potential to reshape pharma industry

Ashwini Prakash, Managing Partner, Stanton Chase India and APAC lead - Pharma, Healthcare, Life Sciences and Consumer products, shares her perspective and observations on current and future trends, diversity and inclusion in pharma industry and how the talent landscape will reshape given the technological advancements in the sector, in an interview with Express Pharma

You have been at the core of hiring leaders for Pharma health care life sciences industry. Due to the ongoing pandemic, what practices and trends do you see will reshape the future of pharma and healthcare industry from the talent perspective?

We are seeing a huge shift in the way healthcare products and services are being consumed, predominantly driven by technology. The disruption caused by pandemic has accelerated digitalisation in the pharma industry. Even the corporates who already embarked on this journey, had to pause, reflect, and revisit their operating model, by slicing and dicing of the processes to carve out portions of the work which have either become redundant or can be digitalised or worked remotely. We might witness a change in the way traditional manufacturing units work in the future. Industry 4.0 will enable increased manufacturing productivity, accurate forecasting and planning, and better supply chain management in the healthcare sector. This will lead to design change and will have a significant impact on talent landscape within the organisations. There will be a new set of emerging competencies to meet this need.